Molecular signatures of tumor progression in pancreatic adenocarcinoma identified by energy metabolism characteristics

Cong Tan(Shanghai Medical College of Fudan University), Midie Xu(Shanghai Medical College of Fudan University), Weiqi Sheng(Shanghai Medical College of Fudan University), Xu Wang(Jiangsu University of Science and Technology), Dan Huang(Chinese PLA General Hospital), Xin Wang(Jiangsu University), Lei Wang(Yuncheng University), Meng Zhang(Scripps Research Institute), Weiwei Weng(Shanghai Medical College of Fudan University), Hesheng Jiang(Guangxi Academy of Fishery Sciences), Shujuan Ni(Shanghai Medical College of Fudan University)
BMC Cancer
April 13, 2022
10.1186/s12885-022-09487-3
Cited by 5

Related Papers

The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer
|International Journal of Cancer|2009|979
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021
|Cancer Communications|2021|657
Perioperative or postoperative adjuvant oxaliplatin with S-1 versus adjuvant oxaliplatin with capecitabine in patients with locally advanced gastric or gastro-oesophageal junction adenocarcinoma undergoing D2 gastrectomy (RESOLVE): an open-label, superiority and non-inferiority, phase 3 randomised controlled trial
|The Lancet Oncology|2021|436
The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2023
|癌症：英文版|2023|412